472 related articles for article (PubMed ID: 10429298)
21. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
22. [Phase II study on preoperative radio-chemo-thermotherapy in locally advanced rectal carcinoma].
Rau B; Wust P; Gellermann J; Tilly W; Hünerbein M; Löffel J; Stahl H; Riess H; Budach V; Felix R; Schlag P
Strahlenther Onkol; 1998 Nov; 174(11):556-65. PubMed ID: 9830436
[TBL] [Abstract][Full Text] [Related]
23. Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma.
Luna-Pérez P; Rodríguez-Ramírez S; Rodriguez-Coria DF; Fernández A; Labastida S; Silva A; López MJ
World J Surg; 2001 Aug; 25(8):1006-11. PubMed ID: 11571965
[TBL] [Abstract][Full Text] [Related]
24. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy analysis of neoadjuvant chemoradiotherapy combined with total pelvic exenteration in the treatment of primary T4b rectal cancer].
Wu T; Wen L; Zhang J; Wu Y; Jiang Y; Chen G; Wang X; Huang S; Wan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):59-65. PubMed ID: 30703795
[TBL] [Abstract][Full Text] [Related]
26. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.
Melton GB; Paty PB; Boland PJ; Healey JH; Savatta SG; Casas-Ganem JE; Guillem JG; Weiser MR; Cohen AM; Minsky BD; Wong WD; Temple LK
Dis Colon Rectum; 2006 Aug; 49(8):1099-107. PubMed ID: 16779712
[TBL] [Abstract][Full Text] [Related]
27. "Sandwich" preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: impact of treatment intensity on local control and survival.
Chan AK; Wong AO; Langevin JM; Jenken DA; Khoo R; Heine JA; Buie WD; Johnson DR
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):629-37. PubMed ID: 9112462
[TBL] [Abstract][Full Text] [Related]
28. Anal sphincter preservation in locally advanced low rectal adenocarcinoma after preoperative chemoradiation therapy and coloanal anastomosis.
Luna-Pérez P; Rodríguez-Ramírez S; Hernández-Pacheco F; Gutiérrez De La Barrera M; Fernández R; Labastida S
J Surg Oncol; 2003 Jan; 82(1):3-9. PubMed ID: 12501163
[TBL] [Abstract][Full Text] [Related]
29. Local recurrence of rectal adenocarcinoma following preoperative radiation therapy and surgery.
Luna-Pérez P; Castro JM; Delgado S; Labastida S; Cruz y Celis M; Herrera L
Arch Med Res; 1992; 23(4):183-8. PubMed ID: 1308702
[TBL] [Abstract][Full Text] [Related]
30. [Preoperative concurrent radiochemotherapy for cancer of the rectum].
Berger C; Kirscher S; Félix-Faure C; Chauvet B; Vincent P; Brewer Y; Reboul F
Cancer Radiother; 1998; 2(3):260-5. PubMed ID: 9749124
[TBL] [Abstract][Full Text] [Related]
31. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
32. Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 2010.
Ghouti L; Pereira P; Filleron T; Humeau M; Guimbaud R; Selves J; Carrere N
Am J Surg; 2015 Feb; 209(2):352-62. PubMed ID: 25524284
[TBL] [Abstract][Full Text] [Related]
33. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
34. [Therapy results of locoregional recurrences in rectal cancer].
Böhm B; Helfritzsch H; Thiele M; Altendorf-Hofmann A; Scheele J
Zentralbl Chir; 2001 Aug; 126(8):596-601. PubMed ID: 11518998
[TBL] [Abstract][Full Text] [Related]
35. Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.
Yamada K; Ishizawa T; Niwa K; Chuman Y; Aikou T
Dis Colon Rectum; 2002 Aug; 45(8):1078-84. PubMed ID: 12195193
[TBL] [Abstract][Full Text] [Related]
36. Preoperative combined radiotherapy and chemotherapy for rectal cancer does not affect early postoperative morbidity and mortality in low anterior resection.
Pucciarelli S; Toppan P; Friso ML; Fornasiero A; Vieceli G; Marchiori E; Lise M
Dis Colon Rectum; 1999 Oct; 42(10):1276-83; discussion 1283-4. PubMed ID: 10528764
[TBL] [Abstract][Full Text] [Related]
37. Total pelvic exenteration for locally advanced rectal carcinoma.
Liu SY; Wang YN; Zhu WQ; Gu WL; Fu H
Dis Colon Rectum; 1994 Feb; 37(2):172-4. PubMed ID: 8306839
[TBL] [Abstract][Full Text] [Related]
38. Pelvic exenteration for recurrent rectal cancer.
Avradopoulos KA; Vezeridis MP; Wanebo HJ
Adv Surg; 1996; 29():215-33. PubMed ID: 8720005
[TBL] [Abstract][Full Text] [Related]
39. Preoperative concomitant radiochemotherapy and IORT in locally advanced rectal cancer.
Crucitti F; Sofo L; Ratto C; Battista Doglietto G; Bellantone R; Nucera P; Bossola M; Ranieri R; Perilli W; Azario L
Rays; 1995; 20(2):197-207. PubMed ID: 7480868
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression.
Eich HT; Stepien A; Zimmermann C; Hellmich M; Metzger R; Hölscher A; Müller RP
Strahlenther Onkol; 2011 Apr; 187(4):225-30. PubMed ID: 21424305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]